Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, making it distinct from approved agents such as semaglutide (Wegovy) and tirzepatide (Mounjaro)
Researched For Both components have been independently studied in models of tendon and ligament injury, with researchers examining cellular proliferation, collagen synthesis markers, and tissue architecture in treated versus control groups
Best Pract Res Clin Endocrinol Metab (2005) 19(1):1732
Our clinicians keep the patient at the centre of the journey and support them every step of the way
It typically presents as sudden, painless vision loss in one eye, often with an altitudinal visual field defect (loss of the top or bottom part of vision)
Abnormal intestinal permeability to sugars in villous atrophy